Main scientific publications (Danielle Dupont)

  • RUSSELL A, BERESNIAK A, BESSETTE L, HARAOUI B, RAHMAN P, THORNE C, MACLEAN R, DUPONT D. Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis. Clin Rheumatol. 2008 Published online Dec. 2008; DOI 10.1007/s10067-008-1060-4.
  • SARAUX A, GOSSEC L, GOUPILLE P, BREGMAN B, BOCCARD E, DUPONT D, BERESNIAK A. Cost-Effectiveness Modelling of Biological Treatment Sequences in Moderate to Severe Rheumatoid Arthritis in France. Rheumatology (Oxford) 2010; 49(4): 733-40.
  • BERESNIAK A, GOSSEC L, GOUPILLE P, SARAUX A, BAMBERGER M, BREGMAN B, DUPONT D. Direct Cost-Modeling of Rheumatoid Arthritis According to Disease Activity Categories in France.  J Rheumatol March 1, 2011 38(3):  439-445; (published online before print December 1 2010, doi: 10.3899/jrheum.100589).
  • CIMMINO M, LEARDINI G, SALAFFI F,  INTORCIA M, BELLATRECCIA A, DUPONT D, BERESNIAK A.  Assessing the cost-effectiveness of biologic agents for the management of moderate to severe rheumatoid arthritis in anti-TNF inadequate responders in Italy:   a modelling approach.  Clin Exp Rheumatol. 2011 Jul-Aug;29(4):633-41. Epub 2011 Aug 31
  • BERESNIAK A, ARIZA-ARIZA R, GARCIA-LLORENTE JF, RAMIREZ ARELLANO A, DUPONT D. Modelling Cost-Effectiveness of Biologic Treatments based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain. International Journal of Inflammation  2011; doi:10.4061/2011/727634.
  • KALRA D, SCHMIDT A, POTTS HWW, DUPONT D, SUNDGREN M, DE MOOR G, on behalf of the EHR4CR Research Consortium. Case Report from the EHR4CR Project – A European Survey on Electronic Health Records Systems for Clinical Research. iHealth Connection 2011; 1(2): 108-13.
  • BERESNIAK A, BERTHERAT E, PEREA W, SOGA G, SOULEY R, DUPONT D, HUGONNET S. A Bayesian network approach to the study of historical epidemiological databases: modelling meningitis outbreaks in the Niger. Bull World Health Organ 2012; 90: 412-17A. doi: 10.2471/BLT.11086009
  • BERESNIAK A, BAERWALD C, ZEIDLER H, KRÜGER K, NEUBAEUR AS, DUPONT D, MERKESDAL S. Cost-effectiveness simulation model of biologic strategies for treating to target rheumatoid arthritis in Germany. Clin Exp Rheumatol 2013; 31(3): 400-8.
  • COOREVITS P, SUNDGREN M, KLEIN GO, BAHR A, CLAERHOUT B, DANIEL C, DUGAS M, DUPONT D, SCHMIDT A, SINGLETON P, DE MOOR G, KALRA D. Electronic health records: new opportunities for clinical research. Journal of Internal Medicine 2013; June: doi:10.1111/joim.12119.
  • DE MOOR G, SUNDGREN M, KALRA D, SCHMIDT A, DUGAS M, CLAERHOUT B, KARAKOYUN T, OHMANN C, LASTIC PY, AMMOUR N, KUSH R, DUPONT D, COOREVITS P. Using Electronic Health Records for Clinical Research: the Case of the EHR4CR Project. Journal of Biomedical Informatics 2014 (In press).
  • BERESNIAK A, MEDINA-LARA A, AURAY JP, DE WEVER A, PRAET JC, TARRICONE R, TORBICA A, DUPONT D, LAMURE M, DURU G. Validation of the Underlying Assumptions of the QALY Indicator: Results from the ECHOUTCOME European Project. Pharmacoeconomics 2014 (In press)
  • BERESNIAK A, AURAY JP, DURU G, ARACTINGI S, KRUEGER G, TALARICO S, TSUTANI K, DUPONT D, DE LINARES Y. (2015), Quality of life assessment in cosmetics: specificity and interest of the international BeautyQol instrument. Journal of Cosmetic Dermatology, 14: 260–265. doi: 10.1111/jocd.12156.
  • BERESNIAK A, AURAY JP, DURU G, ARACTINGI S, KRUEGER G, TALARICO S, ADAM AS, PLOT B,  DUPONT D, DE LINARES Y. Impact of pigmentary disorders on quality of life in Japan: Interest of the BeautyQoL  instrument. J Cosmet Laser Ther. 2015 Jul 2:1-5. [Epub ahead of print] dpi10.3109/14764172.2015.1039034
  • DUPONT D, BERESNIAK A, SCHMIDT A, PROEVE J, BOLANOS E, AMMOUR N, SUNDGREN M, ERICSON M, KALRA D, DE MOOR G. Assessing the Financial Impact of Reusing Electronic Health Records Data for Clinical Research: Results from the EHR4CR European Project. J Health Med Informat 2016; 7 (3): 235. doi:10.4172/2157-7420.1000235.
    The European Institute for Innovation through Health Data. Learn Health Sys 2016 1:8. doi: 10.1002/lrh2.10008.